How to interpret a non-stress test (NST) in pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How to Interpret a Non-Stress Test (NST)

Definition and Basic Interpretation

A reactive NST is defined as two or more fetal heart rate accelerations of ≥15 beats/minute above baseline, lasting ≥15 seconds, within a 20-minute observation period at ≥32 weeks gestation (or ≥10 beats/minute for ≥10 seconds before 32 weeks). 1

Technical Performance

  • Monitor fetal heart rate continuously for 20 minutes initially using a cardiotocograph device with continuous-wave Doppler ultrasound 1
  • Position the external transducer on the maternal abdomen to obtain optimal fetal heart rate signal 1
  • If nonreactive after 20 minutes, extend monitoring to 40 minutes before declaring the test nonreactive 1
  • The extended timeframe accounts for fetal sleep cycles, which typically last 20-40 minutes and are the most common cause of nonreactive NST 1

Interpretation Categories

Reactive (Normal) NST

  • Two or more accelerations meeting criteria within 20 minutes 1
  • Highly predictive of fetal well-being with negative predictive value >99.9% 2
  • Stillbirth risk within 1 week is only 0.8 per 1,000 cases (0.08%) 2
  • Associated with favorable fetal outcomes in 85-89% of high-risk pregnancies 3, 4

Nonreactive (Abnormal) NST

  • One or no acceleration meeting criteria after 40 minutes of observation 1
  • Requires immediate further evaluation—never use nonreactive NST alone for delivery decisions 2
  • Associated with significantly increased cesarean section rates for fetal distress and higher perinatal mortality 3

Management Algorithm Based on NST Result

If Reactive NST

  • Continue surveillance at established intervals (weekly or twice-weekly in high-risk pregnancies) 2, 1
  • Combine with amniotic fluid assessment to create modified biophysical profile for comprehensive evaluation 2
  • No additional testing needed unless clinical situation changes 2

If Nonreactive NST

  • Proceed immediately to modified biophysical profile (NST + amniotic fluid) or full biophysical profile 2
  • If BPP score 8-10: Continue surveillance with increased frequency (twice weekly) for preterm pregnancies 2
  • If BPP score ≤6: Deliver immediately, regardless of gestational age 2
  • If oligohydramnios detected: Deliver at term 2
  • At term gestation with nonreactive NST: This is an indication for delivery 5, 2

What NST Actually Measures

  • NST provides real-time assessment of acute fetal oxygenation and acid-base balance 2
  • It does NOT assess chronic placental function (requires amniotic fluid assessment) 2
  • It does NOT evaluate fetal growth (requires biometry) 2
  • NST cannot predict stillbirth from acute events like placental abruption or cord accidents 2, 6

Critical Clinical Context

When to Use NST

  • Reserve for high-risk pregnancies only—routine testing in low-risk pregnancies causes iatrogenic prematurity from false-positive results 2, 1
  • Initiate at 32-34 weeks gestation for most high-risk conditions 2, 1
  • High-risk indications include: hypertensive disorders, diabetes, IUGR, decreased fetal movement, multiple gestations, amniotic fluid abnormalities, advanced maternal age, chronic renal disease, history of unexplained stillbirth 2

Frequency of Testing

  • Weekly or twice-weekly testing is standard clinical practice, though optimal interval lacks rigorous scientific evidence 2, 1
  • Daily or more frequent testing may be indicated in critical situations like growth restriction or abnormal Doppler findings 2

Common Pitfalls to Avoid

  • Never declare NST nonreactive before 40 minutes of monitoring—fetal sleep cycles are the most common cause of apparent nonreactivity 1
  • Consider fetal acoustic stimulation to awaken the fetus and reduce unnecessary interventions 1
  • Do not rely on NST alone when nonreactive—always perform additional testing (BPP or modified BPP) before making delivery decisions 2
  • Pay close attention to fetal heart rate decelerations on NST, as they may identify fetuses at risk for cord accidents 6
  • Remember that false negatives occur in approximately 0.026% of cases, typically associated with cord accidents, abruptio placentae, or congenital anomalies 6

Special Considerations

Modified Biophysical Profile

  • Combining NST with amniotic fluid assessment creates a modified BPP that evaluates both acute (NST) and chronic (amniotic fluid) markers of fetal well-being 2
  • This is the recommended approach rather than NST alone for comprehensive fetal assessment 5, 2

Term Pregnancy Management

  • At term with abnormal NST (nonreactive), delivery is indicated 5, 2
  • Induction of labor is reasonable if no contraindications exist, but cesarean delivery may be warranted due to concerns about fetal well-being and intolerance of labor 5, 7

References

Guideline

Non-Stress Test Protocol for Fetal Monitoring

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Fetal Well-being Assessment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

The nonstress test: a review of 3,000 tests.

American journal of obstetrics and gynecology, 1981

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

The nonstress test: the false negative test.

American journal of obstetrics and gynecology, 1982

Guideline

Management of Term Pregnancy with Non-Reactive NST but Reassuring BPP

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.